Precision Medicine Online: UC launches clinical trial for post-spinal surgery pain management
Precision Medicine Online highlighted a University of Cincinnati Gardner Neuroscience Institute clinical trial applying a personalized approach to pain management that doctors hope can improve post-surgical pain, reduce opioid dependence and reduce length of hospital stays.
More than half of patients who undergo spine surgery report poor pain control, and between 30 and 50 percent experience chronic pain for longer than 12 weeks (the time of routine tissue healing) following surgery.
Led by the University of Cincinnati's Owoicho Adogwa, MD, the trial takes patients' blood and saliva samples to see how their unique genes respond to different medications.
"Drug reactions vary significantly among individuals," Adogwa, assistant professor of neurosurgery in UC's College of Medicine, told Precision Medicine Online. "In spine surgery, traditional 'one size fits all' pain management is often inadequate due to genetic variations in drug metabolism."
Adogwa said early results of the trial have been encouraging, including shorter hospital stays for patients in the active arm of the trial.
Read the Precision Medicine Online story.
Featured photo at top of Dr. Adogwa in surgery. Photo/UC Health.
Related Stories
CCM welcomes new film and media scoring faculty member J.R. Paredes
May 20, 2026
UC College-Conservatory of Music Dean Pete Jutras has announced the appointment of J.R. Paredes as CCM's new Assistant Professor of Film and Media Scoring. His faculty appointment officially begins on Aug. 15, 2026. Paredes is a composer, music producer and audio post-production specialist whose work spans film, television and commercial music. His credits include original scores for feature films and series distributed on platforms such as Apple TV+ and Prime Video, as well as extensive work in sound design and mixing for film and media.
6 ways starting a GLP-1 medication could affect your emotions
May 20, 2026
When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.